Crossmark

Fatty acid synthase inhibitor cerulenin attenuates glioblastoma progression by reducing EMT and stemness phenotypes, inducing oxidative and ER stress response, and targeting PI3K/AKT/NF-κB axis

Crossref DOI link: https://doi.org/10.1007/s12032-025-02697-2

Published Online: 2025-03-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pekmez, Murat https://orcid.org/0000-0002-6150-8372
Mete, Şefika Beyza https://orcid.org/0000-0002-3386-6244
Aksüt, Yunus https://orcid.org/0000-0001-9407-5019
Öğütcü, İrem https://orcid.org/0000-0001-7721-5542
Baştürk, Fatma Nur https://orcid.org/0000-0002-9575-2760
Gerçek, Yusuf Can https://orcid.org/0000-0001-5372-0229
Şengelen, Aslıhan https://orcid.org/0000-0003-2512-319X
Funding

Funding for this research was provided by:

Istanbul Üniversitesi (FYL-2019-34990)

Istanbul University
License Information

Text and Data Mining valid from 2025-03-25

Version of Record valid from 2025-03-25
More Information

Article History

Received: 2 August 2024

Accepted: 19 March 2025

First Online: 25 March 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below